Catalent Stock Hits Record High, Eyes Five-Straight Ahead of Earnings

Catalent appears to be a healthy growth stock for potential investors

facebook X logo linkedin

Catalent, Inc. (NYSE:CTLT) is an American company that operates in the pharmaceutical industry. CTLT provide delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Catalent employs 14,000 people, including approximately 2,500 scientists and technicians, at more than 45 facilities. Catalent’s market cap is currently valued at $21.5 billion. At last check, CTLT was up 3% at $129.97.

The pharmaceutical company will release its fiscal fourth-quarter earnings before the market opens on Monday, August 30. CTLT has outperformed earnings expectations on all four of its most recent earnings reports released. For Q4 of fiscal 2020, Catalent beat analyst estimates by a margin of $0.11 and reported an EPS of $0.90. For Q1 of fiscal 2021, CTLT's EPS decreased to $0.43, still beating expectations by a margin of $0.06. For Q2 of fiscal 2021, Catalent posted an increase in earnings, rising to $0.63 per share. The company also beat estimates by a margin of $0.08. For Q3 of fiscal 2021, CTLT reported an EPS of $0.82 and beat expectations by a margin of $0.08 once again.

Catalent stock has increased by about 47% year-over-year and is up 63% since bottoming at a 52-week low of $79.65 last September. Additionally, shares of CTLT have grown 22% year-to-date and Catalent stock hit an all-time high of $130.48 today, with long-term support stemming from the 30-day moving average. CTLT is now eyeing its fifth-straight daily gain.


Moreover, CTLT has maintained strong growth in recent year, which has caused Catalent stock to trade at very high price-earnings ratio of 42.75. Overall, the pharmaceutical brand's exceptional and consistent fundamentals makes Catalent stock a viable growth play. However, CTLT’s forward price-earnings ratio of 38.02 means Catalent stock has already priced in a multiple years of growth.

Lastly, analysts are looking optimistic ahead of earnings. Heading into Wednesday's trading, eight of the nine covering brokerage firms posted a "buy" or "strong buy" recommendation.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI